Provided by Tiger Trade Technology Pte. Ltd.

FOSUN INTL

3.820
-0.060-1.55%
Volume:17.45M
Turnover:66.92M
Market Cap:31.20B
PE:-7.14
High:3.900
Open:3.900
Low:3.780
Close:3.880
52wk High:6.810
52wk Low:3.724
Shares:8.17B
HK Float Shares:8.17B
Volume Ratio:0.87
T/O Rate:0.21%
Dividend:0.02
Dividend Rate:0.53%
EPS(LYR):-0.535
ROE:-1.01%
ROA:-0.58%
PB:0.23
PE(LYR):-7.14
PS:0.15

Loading ...

Ardelyx FY 2025 product supply revenue rises 36% to USD 15.88 million

Reuters
·
Feb 20

FDA Approves IND Application for Shanghai Henlius Biotech HLX15-SC in Multiple Myeloma

Reuters
·
Feb 16

Shanghai Fosun Pharmaceutical Subsidiary Drug Registration Application Accepted

Reuters
·
Feb 13

Yuyuan Receives Regulatory Query After Reporting $4.8 Billion Loss, Signaling Challenges for Fosun and Guo Guangchang

Deep News
·
Feb 12

Shanghai Henlius Biotech Receives NMPA Approval for HLX15-SC IND Application

Reuters
·
Feb 12

Fosun-Owned Fidelidade Eyes Over 3 Billion Euro Lisbon IPO, Bloomberg Says, Citing Sources

Dow Jones
·
Feb 11

Guo Guangchang Sells 4.726 Million Shares of CQRC BANK (03618) at HK$6.10 Per Share

Stock News
·
Feb 11

Shanghai Henlius Biotech Doses First Patient in Phase 1b/2 Trial of HLX43 Combination for Advanced Colorectal Cancer

Reuters
·
Feb 11

Vobile Group Partners with Finloop to Tokenize Cultural Creative IP Assets

Reuters
·
Feb 11

Shanghai Fosun Pharmaceutical Subsidiary Drug Registration Application Accepted

Reuters
·
Feb 10

Sisram Medical Showcases Intelligent Aesthetics Innovations at IMCAS World Congress 2026

Reuters
·
Feb 06

Shanghai Fosun Pharmaceutical Subsidiary Drug Registration Application Accepted

Reuters
·
Feb 05

Shanghai Henlius Biotech schließt Lizenzvereinbarung mit Eisai für Hansizhuang in Japan

Reuters
·
Feb 05

BRIEF-Fosun International Says Unit Enters Capital Increase Agreement

Reuters
·
Feb 04

Shanghai Fosun Pharmaceutical Announces Date for First Extraordinary General Meeting in 2026

Reuters
·
Feb 04

Fosun International (00656) Announces RMB105 Million Capital Increase in Zhejiang Shangmeng Technology, Acquiring 51.0879% Stake

Bulletin Express
·
Feb 04

FOSUN INTL Subsidiary to Invest 105 Million Yuan for 51.09% Stake in Shangmeng Technology

Stock News
·
Feb 04

Fosun Commercial Development Acquires Majority Stake in Shangmeng Technology

Reuters
·
Feb 04

Fosun International - Unit Enters Capital Increase Agreement With Zhejiang Shangmeng Technology

THOMSON REUTERS
·
Feb 04

Fosun Pharma Issues RMB1 Billion Scientific and Technological Innovation Bonds

Reuters
·
Feb 03